HK1035143A1 - Pharmaceutical combinations containing tramadol for the production of a medicament for the treatment of migraine or migrainoid headaches - Google Patents
Pharmaceutical combinations containing tramadol for the production of a medicament for the treatment of migraine or migrainoid headachesInfo
- Publication number
- HK1035143A1 HK1035143A1 HK01105795A HK01105795A HK1035143A1 HK 1035143 A1 HK1035143 A1 HK 1035143A1 HK 01105795 A HK01105795 A HK 01105795A HK 01105795 A HK01105795 A HK 01105795A HK 1035143 A1 HK1035143 A1 HK 1035143A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- migrainoid
- headaches
- migraine
- medicament
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19807535A DE19807535A1 (de) | 1998-02-21 | 1998-02-21 | Pharmazeutische Kombinationen mit Tramadol |
| PCT/DE1999/000428 WO1999042095A1 (de) | 1998-02-21 | 1999-02-17 | Pharmazeutische kombinationen mit tramadol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1035143A1 true HK1035143A1 (en) | 2001-11-16 |
Family
ID=7858642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK01105795A HK1035143A1 (en) | 1998-02-21 | 2001-08-17 | Pharmaceutical combinations containing tramadol for the production of a medicament for the treatment of migraine or migrainoid headaches |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1056448B1 (pt) |
| JP (1) | JP2002503689A (pt) |
| KR (1) | KR100567154B1 (pt) |
| CN (1) | CN1141937C (pt) |
| AR (1) | AR018102A1 (pt) |
| AT (1) | ATE257700T1 (pt) |
| AU (1) | AU748993B2 (pt) |
| BG (1) | BG64888B1 (pt) |
| BR (1) | BR9909211A (pt) |
| CZ (1) | CZ291941B6 (pt) |
| DE (2) | DE19807535A1 (pt) |
| DK (1) | DK1056448T3 (pt) |
| EA (1) | EA002166B1 (pt) |
| ES (1) | ES2212549T3 (pt) |
| HK (1) | HK1035143A1 (pt) |
| HU (1) | HU225656B1 (pt) |
| IL (1) | IL137505A (pt) |
| NO (1) | NO327860B1 (pt) |
| NZ (1) | NZ506020A (pt) |
| PL (1) | PL204075B1 (pt) |
| PT (1) | PT1056448E (pt) |
| SK (1) | SK284937B6 (pt) |
| TR (1) | TR200002411T2 (pt) |
| TW (1) | TWI228040B (pt) |
| WO (1) | WO1999042095A1 (pt) |
| ZA (1) | ZA991212B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002531431A (ja) * | 1998-12-02 | 2002-09-24 | ダーウィン・ディスカバリー・リミテッド | 治療用製品およびその使用 |
| DE19940944B4 (de) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| DE60107393T2 (de) | 2000-03-01 | 2005-12-01 | Euro-Celtique S.A. | Verwendung von tramadol zur herstellung eines arzneimittels zur behandlung von funktionelle gastrointestinale krankenheiten |
| US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
| DE10108122A1 (de) | 2001-02-21 | 2002-10-02 | Gruenenthal Gmbh | Arzneimittel auf Basis von Tramadol |
| DE10361596A1 (de) * | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102004020220A1 (de) * | 2004-04-22 | 2005-11-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
| US7553858B2 (en) * | 2003-12-17 | 2009-06-30 | Meda Pharma Gmbh & Co. Kg | Combination of flupirtine and tramadol |
| SI2124556T1 (sl) | 2006-10-09 | 2015-01-30 | Charleston Laboratories, Inc. | Farmacevtske sestave |
| US8124126B2 (en) | 2008-01-09 | 2012-02-28 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
| EP2756756B1 (en) | 2008-04-28 | 2016-01-06 | Zogenix, Inc. | Novel formulations for treatment of migraine |
| US20130213393A1 (en) | 2009-12-22 | 2013-08-22 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| EP2451274B1 (en) | 2009-07-08 | 2017-10-04 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
| US20150290211A1 (en) * | 2014-04-10 | 2015-10-15 | Locl Pharma, Inc. | Pharmaceutical compositions |
| JP2019507181A (ja) | 2016-03-04 | 2019-03-14 | チャールストン ラボラトリーズ，インコーポレイテッド | 医薬組成物 |
| CA3047088A1 (en) | 2016-12-15 | 2018-06-21 | Evoke Pharma, Inc. | Treatment of moderate and severe gastroparesis |
| JP7195660B1 (ja) | 2021-09-09 | 2022-12-26 | 壽製薬株式会社 | 口腔内崩壊錠 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4309408A (en) * | 1978-11-16 | 1982-01-05 | Beecham Group Limited | Effervescent powders |
| AU528098B2 (en) * | 1978-11-16 | 1983-04-14 | Beecham Group Plc | Analgesic tablet |
| CA2020018A1 (en) * | 1990-06-27 | 1991-12-28 | Don L. Simmons | Method and composition for treating the migraine complex |
| GB9214184D0 (en) * | 1992-07-03 | 1992-08-12 | Smithkline Beecham Plc | Pharmaceuticals |
| FR2712809B1 (fr) * | 1993-11-26 | 1996-04-12 | Union Pharma Scient Appl | Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide. |
| FR2720936B1 (fr) * | 1994-06-08 | 1997-04-30 | Synthelabo | Poudres à base de métoclopramide et de paracétamol ou de dérivés d'acide acétylsalicylique. |
| GB9523566D0 (en) * | 1995-11-17 | 1996-01-17 | Euro Celtique Sa | Pharmaceutical formulation |
| FR2741532B1 (fr) * | 1995-11-28 | 1998-08-21 | Bouchara Sa | Nouvelles compositions pharmaceutiques a action antimigraineuse et leur mode de preparation |
| GB2313309B (en) * | 1996-05-24 | 2000-01-26 | Ninh Thuy On | Pharmaceutical compositions comprising a nonsteroidal anti-inflammatory drug and domperidone in the treatment of migraine |
-
1998
- 1998-02-21 DE DE19807535A patent/DE19807535A1/de not_active Withdrawn
-
1999
- 1999-02-16 ZA ZA9901212A patent/ZA991212B/xx unknown
- 1999-02-17 IL IL13750599A patent/IL137505A/xx not_active IP Right Cessation
- 1999-02-17 PL PL342546A patent/PL204075B1/pl unknown
- 1999-02-17 WO PCT/DE1999/000428 patent/WO1999042095A1/de active IP Right Grant
- 1999-02-17 PT PT99916744T patent/PT1056448E/pt unknown
- 1999-02-17 CN CNB998031224A patent/CN1141937C/zh not_active Expired - Fee Related
- 1999-02-17 KR KR1020007009151A patent/KR100567154B1/ko not_active IP Right Cessation
- 1999-02-17 ES ES99916744T patent/ES2212549T3/es not_active Expired - Lifetime
- 1999-02-17 NZ NZ506020A patent/NZ506020A/en not_active IP Right Cessation
- 1999-02-17 CZ CZ20002939A patent/CZ291941B6/cs not_active IP Right Cessation
- 1999-02-17 SK SK1217-2000A patent/SK284937B6/sk not_active IP Right Cessation
- 1999-02-17 AU AU35148/99A patent/AU748993B2/en not_active Ceased
- 1999-02-17 BR BR9909211-5A patent/BR9909211A/pt not_active Application Discontinuation
- 1999-02-17 AT AT99916744T patent/ATE257700T1/de active
- 1999-02-17 EP EP99916744A patent/EP1056448B1/de not_active Expired - Lifetime
- 1999-02-17 JP JP2000532112A patent/JP2002503689A/ja active Pending
- 1999-02-17 DK DK99916744T patent/DK1056448T3/da active
- 1999-02-17 TR TR2000/02411T patent/TR200002411T2/xx unknown
- 1999-02-17 DE DE59908305T patent/DE59908305D1/de not_active Expired - Lifetime
- 1999-02-17 EA EA200000862A patent/EA002166B1/ru not_active IP Right Cessation
- 1999-02-17 HU HU0100964A patent/HU225656B1/hu not_active IP Right Cessation
- 1999-02-20 TW TW088102487A patent/TWI228040B/zh not_active IP Right Cessation
- 1999-02-23 AR ARP990100707A patent/AR018102A1/es not_active Application Discontinuation
-
2000
- 2000-08-18 NO NO20004143A patent/NO327860B1/no not_active IP Right Cessation
- 2000-09-12 BG BG104758A patent/BG64888B1/bg unknown
-
2001
- 2001-08-17 HK HK01105795A patent/HK1035143A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1035143A1 (en) | Pharmaceutical combinations containing tramadol for the production of a medicament for the treatment of migraine or migrainoid headaches | |
| IL219397A0 (en) | Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same | |
| IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
| HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
| HUP9801283A3 (en) | Use of tomoxetin for the production of medicaments against attention-deficit/hyperactivity disorder | |
| HK1047229A1 (en) | Pharmaceutical tramadol salts | |
| AU1609702A (en) | Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism | |
| IL136960A0 (en) | Combination therapy for the treatment of migraine | |
| IL153505A0 (en) | Dds compound and process for the preparation thereof | |
| HUP0202396A3 (en) | Medicaments useful for treating fractures | |
| HUP0103826A2 (hu) | Eljárás zofenopril kalciumsó előállítására és a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása | |
| AU2001285156A1 (en) | Combination therapy for the treatment of migraine | |
| HUP0001891A3 (en) | Medicament for the treatment of migraine | |
| CZ20011872A3 (cs) | Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny | |
| IL136962A0 (en) | Combination therapy for the treatment of migraine | |
| AU3071899A (en) | Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma | |
| IL136024A0 (en) | Combination therapy for the treatment of migraine | |
| KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia | |
| IL127227A0 (en) | A pharmaceutical composition for the treatment of multiple sclerosis | |
| HUP0100661A3 (en) | Salts of paroxetine, process for their preparation and medicaments containing the compounds | |
| SI1150702T1 (en) | Use of orosomucoid for the production of a pharmaceutical preparation for the treatment of pancreatitis | |
| AP2000001896A0 (en) | Improved process for maintaining the stabillity of the fortification | |
| IL130550A0 (en) | Process for the preparation of an enantiomerically enriched 1-(1,4-benzodioxan-2-ylcarbonyl)piperazine(BDCP) | |
| ZA981918B (en) | Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders | |
| HUP0000679A3 (en) | Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170217 |